Gene fusions, which arise from chromosomal rearrangements, are recognised as a significant driver of oncogenesis. They result in chimeric transcripts that can encode novel protein functions, ...

Merus N.V. announced that the New England Journal of Medicine published results from the eNRGy trial for Bizengri® (zenocutuzumab), an innovative treatment for adults with advanced pancreatic ...

Despite decades of progress in pediatric oncology, outcomes for children with high-risk or recurrent rhabdomyosarcoma (RMS) remain discouragingly low. While some patients with intermediate-risk ...

The FDA granted its first approval for a systemic therapy for patients with non-small cell lung cancer with an Neuregulin 1 gene fusion. The Food and Drug Administration (FDA) has granted its first ...